What Is Journavx? First Pain Medication Approved by FDA in Over Two Decades
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
Santa Rosa Press Democrat10m
Artificial intelligence is bringing nuclear power back from the dead — maybe even in California
Energy demands from big tech, including for AI, has elected officials giving an old power source a second look.
Fate Therapeutics' SWOT analysis: stock poised for catalysts amid clinical progress
Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...